Published 4 years ago

Japan to agree supply deal soon for AstraZeneca's coronavirus vaccine

Summary by Reuters

The Japanese government will soon agree a supply deal for more than 100 million doses of a coronavirus vaccine being developed by AstraZeneca Plc (AZN.L), Kyodo news agency reported on Friday.

0 Articles

All

Left

Center

Right

Yahoo News

Japan to agree supply deal soon for AstraZeneca's coronavirus vaccine

4 years ago·Los Angeles, United States

Read Full Article

News18 India

Japan in deals with AstraZeneca, Novavax for COVID-19 vaccines

Japan plans to buy AstraZeneca Plc's experimental COVID19 vaccine and fund a local company to manufacture Novavax's vaccine candidate, ramping up its stockpile plan as it battles surging infections.

4 years ago·India

Read Full Article

Reuters

Japan to agree supply deal soon for AstraZeneca's coronavirus vaccine

The Japanese government will soon agree a supply deal for more than 100 million doses of a coronavirus vaccine being developed by AstraZeneca Plc , Kyodo news agency reported on Friday.

4 years ago·United Kingdom

Read Full Article

The Star Kuala Lumpur

Japan to agree supply deal soon for AstraZeneca's coronavirus vaccine

TOKYO (Reuters) - The Japanese government will soon agree a supply deal for more than 100 million doses of a coronavirus vaccine being developed by AstraZeneca Plc, Kyodo news agency reported on Friday.

4 years ago·Malaysia

Read Full Article

Channel News Asia

Japan announces deal to purchase AstraZeneca's COVID-19 vaccine

Japan has agreed to acquire 120 million doses of AstraZeneca Plc's experimental COVID-19 vaccine if it is successfully developed, the health minister said on Friday.

4 years ago·Singapore

Read Full Article

Arab News

Japan in deal to purchase AstraZeneca’s COVID-10 vaccine

Author: ReutersID: 1596792643730342600Fri, 2020-08-07 09:28 TOKYO: Japan has agreed to acquire 120 million doses of AstraZeneca’s experimental COVID-19 vaccine if it is successfully developed, the health minister said on Friday. The agreement comes after Japan announced a deal last week to buy 120 million doses of a COVID-19 vaccine candidate developed by Pfizer Inc. and BioNTech.Main category: WorldTags: CoronavirusJapan Big data may help gui…

4 years ago·Riyadh, Saudi Arabia

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.